[1] |
World Health Organization. Global status report on noncommunicable diseases 2014[R]. 2015.
|
[2] |
陈伟伟,高润霖,刘力生,等. 《中国心血管病报告2015》概要[J]. 中国循环杂志,2016,31(6):521-528.
|
[3] |
D'AGOSTINO R B SR,VASAN R S,PENCINA M J,et al. General cardiovascular risk profile for use in primary care:the Framingham Heart Study[J]. Circulation,2008,117(6):743-753.
|
[4] |
RIDKER P M,BURING J E,RIFAI N,et al.Development and validation of improved algorithms for the assessment of global cardiovascular risk in women:the Reynolds Risk Score[J]. JAMA,2007,297(6):611-619.
|
[5] |
RIDKER P M,PAYNTER N P,RIFAI N,et al.C-reactive protein and parental history improve global cardiovascular risk prediction:the Reynolds Risk Score for men[J]. Circulation,2008,118(22):2243-2251.
|
[6] |
CONROY R M,PYÖRÄLÄ K,FITZGERALD A P,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe:the SCORE project[J]. Eur Heart J,2003,24(11):987-1003.
|
[7] |
HIPPISLEY-COX J,COUPLAND C,VINOGRADOVA Y,et al.Predicting cardiovascular risk in England and Wales:prospective derivation and validation of QRISK2[J]. BMJ,2008,336(7659):1475-1482.
|
[8] |
国人缺血性心血管病发病危险的评估方法及简易评估工具的开发研究[J]. 中华心血管病杂志,2003,31(12):893-901.
|
[9] |
中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016修订版)[J]. 中国循环杂志,2016,31(10):937-950.
|
[10] |
袁绍华,张新超. 心血管疾病风险评估方法及存在问题[J]. 中国心血管杂志,2011,16(3):223-226.
|
[11] |
中国医师协会心血管内科医师分会,《中华内科杂志》编辑委员会. 心血管疾病一级预防中国专家共识[J]. 中华内科杂志,2010,49(2):174-185.
|
[12] |
金雪娟,周京敏,周俊,等. 新危险因素在预测中年男性缺血性心血管病20年发病风险中的作用[J]. 中华流行病学杂志,2016, 37(3):335-338.
|
[13] |
EICHLER K,PUHAN M A,STEURER J,et al.Prediction of first coronary events with the Framingham score:a systematic review[J]. Am Heart J,2007,153(5):722-731.
|
[14] |
HIPPISLEY-COX J,COUPLAND C,VINOGRADOVA Y,et al.Derivation and validation of QRISK,a new cardiovascular disease risk score for the United Kingdom:prospective open cohort study[J]. BMJ,2007,335(7611):136.
|
[15] |
HIPPISLEY-COX J,COUPLAND C,VINOGRADOVA Y,et al.Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice:a validation study[J]. Heart,2008,94(1):34-39.
|
[16] |
COLLINS G S,ALTMAN D G.An independent external validation and evaluation of QRISK cardiovascular risk prediction:a prospective open cohort study[J]. BMJ,2009,339:b2548.
|
[17] |
RIDKER P M.A test in context:high-sensitivity C-reactive protein[J]. J Am Coll Cardiol,2016,67(6):712-723.
|
[18] |
WALLDIUS G,JUNGNER I,HOLME I,et al.High apolipoprotein B,low apolipoprotein A-I,and improvement in the prediction of fatal myocardial infarction(AMORIS study):a prospective study[J]. Lancet,2001,358(9298):2026-2033.
|
[19] |
ANDERSON T J,GRÉGOIRE J, HEGELE R A,et al. 2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult[J]. Can J Cardiol,2013,29(2):151-167.
|
[20] |
GOFF D C JR,LLOYD-JONES D M,BENNETT G,et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. Circulation,2014,129(25 Suppl 2):S49-S73.
|
[21] |
LEVEY A S,STEVENS L A,SCHMID C H,et al.A new equation to estimate glomerular filtration rate[J]. Ann Intern Med,2009,150(9):604-612.
|